Introduction

It is estimated that 31% of all deaths globally i.e. 17.5 million deaths occurred due to cardiovascular disease in 2014 [1]. In India, mortality due to cardiovascular disease was expected to rise by 103% in men and by 90% in women from 1985 to 2015 [2].

References

1. The World Health Organization. Global status report on non-communicable diseases (2014).
2. Bulatao RA and Stephens PW. “Global estimates and projections of mortality by cause, 1970-2015”. Washington: Population Health and Nutrition Department, World Bank (1992).
3. Maahs DM., et al. “Dyslipidemia in youth with diabetes: to treat or not to treat?” The Journal of Pediatrics 153 (2008): 458-465.
4. Haney EM., et al. “Screening for Lipid Disorders in Children and Adolescent”. Rockville, MD: Agency for Healthcare Research and Quality (US) (2007).
5. Genest JG Jr. “Dyslipidemia and coronary artery disease”. Canadian Journal of Cardiology 16 (2000): 3A-4A.
6. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report”. Pediatrics5 (2011): S213-S256.
7. Holman RL., et al. “The natural history of atherosclerosis. The early aortic lesions as seen in the middle of 20th century”. The American Journal of Pathology 34 (1958): 209-235.
8. Stary HC. “Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults”. Arteriosclerosis1 (1980): 119-132.
9. Gotto AM Jr. “Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report”. Circulation 103 (2001): 2213-2218.
10. Daniels SR. “Screening and treatment of dyslipidemias in children and adolescents”. Hormone Research in Paediatrics 1 (2011): 47-51.
11. Psaty BM and Rivara FP. “Universal screening and drug treatment of dyslipidemia in children and adolescents”. The Journal of the American Medical Association 307 (2012): 257-258.
12. Hatami M., et al. “Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population”. Lipids in Health and Disease (2012): 11-107.
13. Zachariah JP and De Ferranti SD. “NHLBI integrated pediatric guidelines: Battle for a future free of cardiovascular disease”. Future Cardiology 9 (2013): 13-22.
14. Rajesh Dholarpuria., et al. “Atherosclerosis risk factors in adolescents”. Indian Journal of Pediatrics (2007): 823-826.
15. Anita K., et al. “Lipid profile norms in Indian children”. Indian Pediatrics 4 (1995): 1177-1180.
16. Ambady R., et al. “Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in Southern India”. Diabetes Care (2007): 1828-1833.
17. Parmar IB., et al. “Lipid profile in the progeny of parents with ishchemic heart disease”. Indian Journal of Pediatrics 68 (2001): 617-621.
18. Anand NK., et al. “Lipid profile in children of 5-15 years age with parental history of IHD, Hypertension, Diabetes Mellitus”. Indian Pediatrics 39 (2002): 168-172.
19. Khalil A., et al. “Insulin resistance and lipid profile in the children of young ischemic parents”. Indian Pediatr 40 (2003): 556-560.
20. Ghulati S and Saxena A. “Study of lipid profile in children of parents with premature coronary artery disease”. Indian Pediatrics 40 (2003): 556-560.
21. Agarwal A., et al. “Prevalence of dyslipidemia in students aged 6-16 years in a private school of rural Jaipur”. Indian Journal of Basic and Applied Medical Research1 (2016): 658-662.

Citation

Citation: Abu Bashar. “Prevalence and Determinants of Dyslipidaemia among Children and Adolescents in India: Findings from a Large Representative Survey". Acta Scientific Clinical Case Reports 1.11 (2020): 40-41.

Copyright

Copyright: © 2020 Abu Bashar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.